Business News <\/p>\n
Fujifilm Healthcare Corporation is transferring its business related to EMR and medical receipt systems to PHC Holdings Corporation, owner of the Medicom medical information systems, following a stock purchase agreement.<\/span><\/p>\n According to a press statement, PHC’s latest subsidiary Wemex Corporation will acquire all shares of Fujifilm Healthcare Corporation’s EMR and medical receipt business. The acquisition is expected to be completed in October.\u00a0<\/span><\/p>\n WHY IT MATTERS<\/span><\/strong><\/p>\n Wemex is the result of the integration of PHC’s Medicom business and PHC Medicom Corporation. It is now providing all Medicom-branded medical information systems, including EMR, medical receipt, and medication history systems, as well as digital solutions for pharmacy management, healthy lifestyle guidance, and telemedicine systems.<\/span><\/p>\n Through its acquisition of the Fujifilm business, it is expanding its portfolio of digital health solutions and customer base. Soon, it will be able to\u00a0deliver one-stop solutions for healthcare providers by\u00a0<\/span>connecting\u00a0different medical information management systems.<\/span><\/p>\n Meanwhile, Fujifilm, which is currently optimising its medical systems portfolio, decided to sell its EMR and medical receipt systems business thinking that “it would be best that it\u00a0will be developed and grown by PHC, <\/span>which has a strong market presence in the electronic medical record and medical-receipt systems for clinics in Japan and can expect synergies in sales and customer support.”<\/p>\n THE LARGER TREND<\/span><\/strong><\/p>\n Fujifilm further shared that it plans to focus on accelerating the deployment of its medical IT solutions, including SYNAPSE, and its medical support platform. It will also continue developing AI technology for assisting medical diagnostic imaging, facilitating frontline staff workflow, and delivering maintenance services for medical equipment.\u00a0“By swiftly providing products and services that utilise its AI technology, Fujifilm will achieve continuous growth in its medical systems business while contributing to solving social issues such as early detection of diseases, addressing unmet medical needs, and improving access to medical services,” the company explained.<\/span><\/p>\n Among its latest AI innovation is <\/span>AI Technology for AD Progression Prediction<\/a>. It can predict whether a patient can progress to having Alzheimer’s disease within two years by looking at atrophy patterns on 3D MRI brain images.<\/p>\n Another example is <\/span>Fujifilm CXR-AID<\/a>, which detects abnormal findings from chest x-rays with 97%-99% accuracy. The software solution obtained clearance from Japan’s Pharmaceuticals and Medical Devices Agency in 2021.<\/p>\n